Genetics Review for CSD Professionals

Fundamentals of Genetics and the Central Dogma

• The Central Dogma of Molecular Biology:
  • Governs the directional flow of genetic information within biological systems: $\text{DNA} \rightarrow \text{RNA} \rightarrow \text{Protein}$.
  • Transcription: Occurs inside the nucleus, where a specific DNA sequence is transcribed into messenger RNA ($\text{mRNA}$).
  • Nuclear Export: The mature $\text{mRNA}$ transcript is transported out of the nucleus into the cytoplasm.
  • Translation: Synthesizes a specific polypeptide chain at the ribosome using $\text{mRNA}$ as a template.

• Nucleic Acid Structure and Composition:
  • Nucleic acids are long-chain polymers composed of nucleotide monomeric units.
  • Each nucleotide consists of three structural components:
  1. A pentose sugar molecule.
  2. A phosphate group.
  3. A nitrogenous base.
  • Nucleic acids are classified and named according to their sugar backbone (Deoxyribose vs. Ribose).

• Comparison of DNA and RNA:
  • Deoxyribonucleic Acid (DNA):
  • Double-stranded helical structure.
  • Contains deoxyribose sugar.
  • Nitrogenous bases: Cytosine ($C$), Guanine ($G$), Adenine ($A$), and Thymine ($T$).
  • Ribonucleic Acid (RNA):
  • Single-stranded structure.
  • Contains ribose sugar.
  • Nitrogenous bases: Cytosine ($C$), Guanine ($G$), Adenine ($A$), and Uracil ($U$).

• Transfer RNA (tRNA) Functional Domains:
  • Acceptor Stem: Site of amino acid attachment at the $3'$ end.
  • D Arm: Stabilizes tRNA tertiary structure.
  • T Arm: Facilitates ribosome recognition during translation.
  • Variable Loop: Contributes to structural variation among different tRNAs.
  • Anticodon Arm: Contains the three-nucleotide anticodon sequence that pairs complementarily with $\text{mRNA}$ codons.

• DNA Packaging Hierarchy:
  • DNA double helix wraps around histone protein octamers to form nucleosomes ("beads on a string").
  • Nucleosomes pack tightly into coiled chromatin fibers.
  • Chromatin fibers loop into higher-order chromatin loops.
  • Chromatin loops further condense to construct functional chromosomes during nuclear division.

• Anatomy of a Chromosome:
  • $p$ arm: Short arm of the chromosome (derived from French petit).
  • $q$ arm: Long arm of the chromosome.
  • Centromere: Primary constriction point separating the $p$ and $q$ arms; essential for chromosome segregation during mitosis/meiosis.
  • Telomere: Repetitive nucleotide sequences at terminal ends that protect chromosomes from degradation.

• Genes and Chromosomal Loci:
  • Gene: Defined physical and functional unit of heredity made of DNA sequences coding for specific functional proteins or traits.
  • Allele: Variant form of a given gene located at a specific chromosomal position.
  • Locus: Specific geographical coordinate/address of a gene on a chromosome.
  • Standard Nomenclature Example: Cystic Fibrosis Transmembrane Conductance Regulator ($CFTR$) gene located at $7q31.2$:
  • $7$ = Chromosome 7.
  • $q$ = Long arm.
  • $3$ = Region 3.
  • $1$ = Band 1.
  • $.2$ = Sub-band 2.

• Online Mendelian Inheritance in Man (OMIM):
  • Authoritative online catalog of human genes and genetic disorders located at omim.org.
  • Provides data regarding mapped loci, modes of inheritance, clinical synopses, and related gene families.

Protein Synthesis and Higher-Order Structural Organization

• Translational Dynamics and Energetics:
  • $\text{mRNA}$ template code ($5' \rightarrow 3'$ directional strand) is read by ribosomes in triplet codons.
  • Transfer RNA (tRNA) molecules carry specific amino acids matching codon-anticodon base pairs.
  • Energetic Cost: Aminoacyl-tRNA synthetase charging (loading the amino acid onto its cognate tRNA) consumes adenosine triphosphate ($\text{ATP}$) and represents the most energy-intensive step in the protein synthesis cascade.

• Chemical Structure of Amino Acid Chains:
  • Amino acid monomers join via peptide bonds to form polypeptide chains.
  • Structural termini:
  • Amino terminus ($N$-terminus): Free amino group end.
  • Carboxyl/Acid terminus ($C$-terminus): Free carboxyl group end.
  • Variable side chains ($R_1, R_2, R_3, \dots$) determine physical and chemical properties of the protein.

• Hierarchical Levels of Protein Organization:
  • Primary Structure: Linear sequence of amino acids linked by covalent peptide bonds.
  • Secondary Structure: Local folding patterns stabilized by hydrogen bonds along the polypeptide backbone, forming $\alpha$-helices and $\beta$-pleated sheets.
  • Tertiary Structure: Three-dimensional spatial conformation created by interactions between secondary elements and side-chain ($R$ group) interactions.
  • Quaternary Structure: Multi-subunit protein complex assembled from multiple individual polypeptide chains.

• Multilevel Biological Variation:
  • Variations can occur at all levels: single nucleotides (SNPs), transcript splicing ($\text{mRNA}$ processing), structural gene mutations, chromosomal rearrangements, and whole genomes.
  • Epigenetics: Herable changes in gene expression or cellular phenotype caused by mechanisms other than alterations in the underlying DNA sequence.

Clinical Relevance of Genetics in Speech-Language Pathology and Audiology

• Frontline Role of Communication Sciences and Disorders (CSD) Clinicians:

  • Speech-Language Pathologists (SLPs) and Audiologists act as primary clinical observers ("genetic first responders").
  • Clinicians possess expertise in recognizing phenotypic signs and symptoms (craniofacial anomalies, neurodevelopmental delays, dysmorphologies) that suggest underlying genetic etiologies.

• Genetic Correlates of Early Vocabulary Development:

  • Early expressive vocabulary size is significantly governed by heritable genetic factors.
  • Genome-wide studies show genetic links connecting early expressive vocabulary size to literacy development and Attention-Deficit/Hyperactivity Disorder (ADHD) risk factors.
  • Distinct genetic factors regulate vocabulary growth dynamically, with different gene sets activating during the transition from infancy to toddlerhood (Verhoef et al., 2024).

• FOXP2 Gene and Speech-Language Pathology:

  • Locus: Located at $7q31$ (specifically within the $SPCH1$ region).
  • Pathophysiology: Mutations in $FOXP2$ disrupt intracellular motor protein trafficking, impairing synapse formation in motor speech networks.
  • Clinical Manifestation: Causes severe verbal dyspraxia and vocalization deficits.
  • Therapeutic Targets: Experimental knockdowns of interacting proteins (e.g., $DCTN1$) demonstrate potential to reverse cellular synaptic abnormalities (Zhang et al., 2019).

• Chromosomal Loci Implicated in Speech and Language Disorders:

  • Locus $1p$:

  • Associated Disorder: Speech-sound disorder.

  • Method: Targeted linkage.

  • References: Miscimarra et al. (2007).

  • Notes: Region also linked to dyslexia.

  • Locus $1q$:

  • Associated Disorder: Stuttering.

  • Method: Genome-Wide Linkage Analysis (GWLA).

  • References: Riaz et al. (2005).

  • Locus $2q$:

  • Associated Disorder: Stuttering.

  • Method: GWLA.

  • References: Suresh et al. (2006).

  • Notes: Replicated by Wittke-Thompson et al. (2007).

  • Locus $3$:

  • Associated Disorder: Speech-sound disorder.

  • Method: Targeted linkage.

  • References: Stein et al. (2004).

  • Notes: Region also linked to dyslexia.

  • Locus $3p14$ ($FOXP1$):

  • Associated Disorder: Developmental delay with speech and language impairment.

  • Method: Translocation mapping and chromosome abnormality screening.

  • References: Pariani et al. (2009); Carr et al. (2010); Horn et al. (2010); Vernes et al. (2009).

  • Notes: Replicated across several individuals with variable phenotypes.

  • Locus $3q$:

  • Associated Disorder: Stuttering.

  • Method: GWLA.

  • References: Wittke-Thompson et al. (2007).

  • Notes: Linkage to $3q$ also identified by Raza et al. (2010).

  • Locus $5q$:

  • Associated Disorder: Stuttering.

  • Method: GWLA.

  • References: Riaz et al. (2005).

  • Notes: Replicated by Wittke-Thompson et al. (2007).

  • Locus $6p$:

  • Associated Disorder: Speech-sound disorder.

  • Method: Targeted linkage.

  • References: Smith et al. (2005).

  • Notes: Region also linked to dyslexia.

  • Locus $7q31$ ($FOXP2$):

  • Associated Disorder: Verbal dyspraxia.

  • Method: GWLA with subsequent translocation mapping.

  • References: Fisher et al. (1998); Lai et al. (2001).

  • Notes: Disrupted in individuals with verbal dyspraxia; not associated with Specific Language Impairment (SLI) or autism.

  • Locus $7q$:

  • Associated Disorder: Stuttering.

  • Method: GWLA.

  • References: Riaz et al. (2005).

  • Notes: Replicated by Suresh et al. (2006) in male individuals only.

  • Locus $7q36$ ($CNTNAP2$):

  • Associated Disorder: Specific Language Impairment (SLI).

  • Method: Targeted association of candidate gene.

  • References: Vernes et al. (2008).

  • Notes: Associated with broader neurodevelopmental disorders.

  • Locus $9p$:

  • Associated Disorder: Stuttering.

  • Method: GWLA.

  • References: Suresh et al. (2006).

  • Locus $12q23$ ($GNPTAB$):

  • Associated Disorder: Stuttering.

  • Method: GWLA and targeted candidate gene sequencing.

  • References: Kang et al. (2010); Riaz et al. (2005).

  • Notes: Linkage replicated by Suresh et al. (2006) when conditioning on chromosome $7q$ stuttering locus.

  • Locus $13$:

  • Associated Disorder: SLI.

  • Method: GWLA.

  • References: Bartlett et al. (2002).

  • Notes: Replicated by Bartlett et al. (2004).

  • Locus $13q$:

  • Associated Disorder: Stuttering.

  • Method: GWLA.

  • References: Wittke-Thompson et al. (2007).

  • Notes: Overlaps with Bartlett linkage to SLI.

  • Locus $15p$:

  • Associated Disorder: Stuttering.

  • Method: GWLA.

  • References: Suresh et al. (2006).

  • Locus $15q$:

  • Associated Disorder: Stuttering & Speech-sound disorder.

  • Method: GWLA / Targeted linkage.

  • References: Wittke-Thompson et al. (2007); Smith et al. (2005); Stein et al. (2006).

  • Notes: Linked to dyslexia.

  • Locus $16p13$ ($GNPTG$, $NAGPA$):

  • Associated Disorder: Stuttering.

  • Method: Targeted candidate gene sequencing.

  • References: Kang et al. (2010).

  • Locus $16q24$ ($ATP2C2$, $CMIP$):

  • Associated Disorder: SLI.

  • Method: GWLA and targeted association.

  • References: Newbury et al. (2009); SLIC (2002).

  • Notes: Linkage replicated by Falcaro et al. (2008), Monaco (2007), SLIC (2004). $ATP2C2$ is also associated with ADHD (Lesch et al., 2008).

  • Locus $18p$:

  • Associated Disorder: Stuttering.

  • Method: GWLA.

  • References: Shugart et al. (2004).

  • Locus $19q13$:

  • Associated Disorder: SLI.

  • Method: GWLA.

  • References: SLIC (2002); Falcaro et al. (2008); Monaco (2007).

• Genetic Etiology of Hearing Impairments:

  • $50\%$ to $60\%$ of congenital or early-onset hearing loss has a genetic etiology.
  • Breakdown of genetic hearing loss:
  • Nonsyndromic: $70\%$ (hearing loss occurs in isolation).
  • Syndromic: $30\%$ (hearing loss occurs alongside other systemic signs).
  • Over $500$ unique genes have been identified in association with hearing loss.

Interprofessional Competencies and Educational Standards

• ASHA Directives and Interprofessional Frameworks:

  • In 2005, the American Speech-Language-Hearing Association (ASHA) mandated that clinical audiologists and SLPs understand core genetic principles, testing protocols, and counseling mechanisms.
  • ASHA collaborated with the National Coalition for Health Professional Education in Genetics (NCHPEG) to establish standardized core competencies, now maintained by Jackson Laboratory.

• Baseline Competency Requirements:

  • Regularly audit clinical practice to identify genetic knowledge gaps.
  • Recognize the complex social, psychological, and systemic impacts of genetic findings on families.
  • Master referral pathways to certified genetic professionals.

• Knowledge Competencies (1.1–1.11):

  • Maintain proficiency in basic genetic terminology, biological inheritance models, and gene-environment interactions.
  • Distinguish between a clinical diagnosis and an identified genetic predisposition (genetic variation does not equal guaranteed disease manifestation).
  • Analyze client factors influencing access to genetic services (ethnicity, health literacy, financial resources, cultural beliefs).
  • Comprehend Ethical, Legal, and Social Issues (ELSI), including genetic privacy laws and protections against health insurance or employment discrimination under the Genetic Information Nondiscrimination Act (GINA).

• Skill Competencies (2.1–2.5):

  • Systematically gather a genetic family history spanning at least three generations.
  • Identify candidates for genetic consultation and articulate the clinical rationale and benefits of referral to clients.
  • Utilize clinical databases (e.g., OMIM) to evaluate emerging evidence.

• Attitude Competencies (3.1–3.2):

  • Respect client privacy and genetic data confidentiality.
  • Engage in interdisciplinary collaboration with medical geneticists and genetic counselors.

• Current Educational Gaps in Healthcare Training:

  • Survey data reveals that over $80\%$ of practicing SLPs and Audiologists believe they require additional genetic training.
  • More than $33\%$ of Audiologists and $66\%$ of SLPs rate their genetic clinical confidence as low or somewhat low (Peter et al., 2019; Bogavac et al., 2019).
  • The Praxis exam features content where roughly $50\%$ of questions relate directly or indirectly to syndromes and genetic etiologies.

Service Delivery Models, Commercial Genetic Testing, and Data Privacy

• Five Primary Service Delivery Models:

  1. The Geneticist Model: Primary care refers directly to a medical geneticist.
  2. The Primary Care Model: General practitioners conduct initial screening and order genetics panels.
  3. The Medical Specialist Model: Sub-specialists (e.g., otolaryngologists, neurologists) direct disease-specific genetic testing.
  4. The Population Screening Programs Model: Public health infrastructure mandates newborn screenings.
  5. The Direct-to-Consumer (DTC) Model: Consumers order genetic testing directly without provider oversight.

• Shortage of Genetic Professionals vs. DTC Expansion:

  • There are approximately 4,600 certified genetic counselors across the entire United States.
  • Exponential growth in consumer testing created millions of results generated without professional oversight:
  • AncestryDNA: $14.0\,\text{million}$ clients.
  • 23andMe: $9.0\,\text{million}$ clients.
  • Other platforms: $3.5\,\text{million}$ clients.

• Corporate Instability and Genetic Privacy Risks:
  • The decline of commercial genetic testing firms poses severe privacy risks.
  • Case Study (23andMe): A company valued at $\$6\,\text{billion}$ faced potential collapse, jeopardizing the sensitive DNA data of $14\,\text{million}$ individuals.
  • Critical legal and ethical issues include data ownership, corporate asset liquidation, secondary sales to pharmaceutical conglomerates, and unauthorized law enforcement usage.

Clinical Practice Guidelines: Referral Protocols, Communication, and Case Studies

• Four Core Clinical Actions:

  1. Ask: Inquire thoroughly about non-speech medical history.
  2. Ask: Collect a detailed 3-generation family health history.
  3. Educate: Provide clinical education strictly within the CSD scope of practice.
  4. Refer: Direct patients to certified genetic counselors.

• Indications for Genetic Referral (New York-Mid-Atlantic Consortium Standards):

  • One or more family members with intellectual disability, developmental delay, or known structural birth defects.
  • Early unexplained deaths in immediate or extended family.
  • Early-onset adult health conditions (e.g., young-onset dementia, cardiovascular disease, premature cancers).
  • Unexplained developmental delays or infants flagged by state newborn screening programs.

• Pediatric Indications for Genetic Consultation:

  • Neonate presenting with:

  • Abnormal newborn screen $\rightarrow$ Rule out inborn errors of metabolism or treatable metabolic conditions; assess recurrence risks.

  • Congenital hypotonia or hypertonia $\rightarrow$ Rule out chromosomal or syndromic diagnoses (e.g., Prader-Willi syndrome, congenital myotonic dystrophy, hyperekplexia).

  • Unexplained intrauterine growth retardation (IUGR) $\rightarrow$ Rule out Russell-Silver syndrome, trisomy 18, or chromosomal anomalies.

  • Neonate, Infant, or Child presenting with:

  • Single major or multiple major/minor anomalies $\rightarrow$ Rule out syndromic conditions; advise on recurrence risk and preventive measures (e.g., folate supplementation).

  • Non-familial dysmorphic features accompanied by developmental delay or intellectual disability $\rightarrow$ Rule out underlying chromosomal or microdeletion syndromes.

  • Failure to thrive $\rightarrow$ Rule out metabolic disorders, syndromic diagnoses, or growth factor mutations (e.g., $IGF1R$ mutations).

  • Metabolic symptoms (intractable seizures, hepatosplenomegaly, metabolic acidosis, cyclic vomiting, persistent hypoglycemia, regression, unusual body odor) $\rightarrow$ Diagnose inborn errors of metabolism and coordinate management.

  • Abnormal brain MRI findings (leukodystrophy, periventricular calcifications, unspecified structural malformations) $\rightarrow$ Rule out neurofibromatosis, tuberous sclerosis, or genetic brain malformations (e.g., Dandy-Walker malformation).

  • Unusual growth patterns (overgrowth, short stature) $\rightarrow$ Rule out syndromic conditions such as Sotos syndrome.

• Finding Board-Certified Counselors:

  • Direct clients to the National Society of Genetic Counselors (NSGC) directory at nsgc.org.

• Clinical Scripts for Patient Communication:

  • General Explanation Script: "Many communication disorders are influenced by a complex combination of genetics, health history, and environmental factors. If there are questions regarding potential underlying genetic components, a referral to a genetic counselor is recommended. Regardless of whether a genetic cause is identified, effective speech-language therapy can target and improve functional skills."
  • Specific Red-Flag Referral Script: "During our history review, I noted [significant flag]. Research indicates that [significant flag] can sometimes involve genetic factors. I am recommending a consultation with a certified genetic counselor. They will evaluate whether genetic testing is appropriate and can clarify potential causes. I can provide local recommendations, or you can request a direct referral from your primary care physician."
  • Documentation Model Statement: "Patient presents with [observed phenotypic flag], which can indicate genetic involvement. Referral initiated for genetic counseling consultation and diagnostic evaluation as indicated. Local contact resources provided."

• Explicit Clinical Boundaries (What Clinicians Cannot State Without Testing):

  • Unsubstantiated claims regarding whether a disorder is strictly genetic or epigenetic.
  • Definitive statements regarding heritability patterns, recurrence risks, or whether parents/siblings are asymptomatic carriers.

• Case Study Analysis: Chromosome 16 Variants ($16p11.2$):

  • Microduplication ($16p11.2$): Duplicate genomic copy. Phenotypic presentation includes speech-language delays, learning difficulties, heightened autism spectrum susceptibility, minor craniofacial dysmorphic features, motor coordination delays, and a clinical tendency toward being underweight.
  • Microdeletion ($16p11.2$): Deleted genomic copy. Phenotypic presentation includes expressive language delays, intellectual impairment, heightened autism susceptibility, infant hypotonia, and a clinical tendency toward overweight/obesity.
  • Clinical Nuance (Penetrance vs. Expressivity):
  • Variable Penetrance: Not every individual holding the variant displays clinical symptoms.
  • Variable Expressivity: Symptom severity ranges dramatically across individuals (e.g., a child may exhibit severe speech dyspraxia while an inheriting parent displays mild traits).

Terminology and Nosology: Disease, Disorder, Syndrome, and Neurodiversity

• Nosological Definitions in Clinical Practice:

  • Disease: Pathological disruption of normal physiological functioning attributable to an established biological cause/etiology.
  • Disorder: Functional structural or mental disruption causing atypical operations, often resulting from underlying pathology or development.
  • Syndrome: A characteristic combination of clinical signs and symptoms that consistently present together, with single, multiple, or unknown underlying etiologies.

• The Neurodiversity Framework:

  • Etymology: Combined root derived from Neuro (brain) + Diversity (range of variations).
  • Definition: Biological range of variation present across human neurological function.
  • Conceptual Paradigm: Neurodiversity is an objective biological fact of human variation. It is not an opinion, political position, belief system, or theoretical hypothesis.